Potential savings in Mexico from screening and prevention for early diabetes and hypertension

Health Affairs

Volumn 29, Issue 12, 2010, Pages 2171-2179

  Castro Ríos, Angelica ^a   Doubova, Svetlana Vladislavovna ^a   Martínez Valverde, Silvia ^b   Coria Soto, Irma ^c   Perez Cuevas, Ricardo ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^c Carlos Slim Health Institute   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COST CONTROL; EARLY DIAGNOSIS; ECONOMICS; FEMALE; HEALTH CARE SURVEY; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MALE; MASS SCREENING; MEXICO; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; COST SAVINGS; DIABETES MELLITUS, TYPE 2; EARLY DIAGNOSIS; FEMALE; HEALTH CARE SURVEYS; HUMANS; HYPERTENSION; MALE; MASS SCREENING; MEXICO; MIDDLE AGED; PREDIABETIC STATE;

EID: 79953787922     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2010.0819     Document Type: Letter

References (29)

1. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N Engl J Med. 2007;356:213-5.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-23.
3. International Diabetes Federation. IDF diabetes atlas [Internet]. Brussels: The Federation; 2010 Mar 8 [cited 2010 Apr 5]. Available from: http://www.diabetesatlas.org/content/regional-data
4. Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, et al. Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess. 2007; 11(17):1-125.
5. Sipkoff M. Prediabetes: prevalent and preventable but underdiagnosed and undertreated. Manag Care. 2008;17(12):33-4, 40.
6. Greenlund KJ, Croft JB, Mensah GA. Prevalence of heart disease and stroke risk factors in persons with prehypertension in the United States, 1999-2000. Arch Intern Med. 2004;164:2113-8.
7. Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract. 2005;67(2):152-62.
8. Laatikainen T, Dunbar JA, Chapman A, Kilkkinen A, Vartiainen E, Heistaro S, et al. Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project. BMC Public Health. 2007;7:249.
9. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6): 393-403.
10. Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368(9548): 1673-9.
11. Law M, Wald N, Morris J. Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. Health Technol Assess. 2003;7(31):1-94.
12. Zhang Y, Lee ET, Devereux RB, Yeh J, Best LG, Fabsitz RR, et al. Prehypertension, diabetes, and cardiovascular disease risk in a populationbased sample: the Strong Heart Study. Hypertension. 2006;47(3): 410-4.
13. CDC Diabetes Cost-Effectiveness Study Group. The cost-effectiveness of screening for type 2 diabetes. JAMA. 1998;280:1757-63.
14. Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BH, Rutten G. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int J Obes Relat Metab Disord. 2000;24(Suppl 3):S6-11.
15. Hoerger TJ, Harris R, Hicks KA, Donahue K, Sorensen S, Engelgau M. Screening for type 2 diabetes mellitus: a cost-effectiveness analysis. Ann Intern Med. 2004;140: 689-99.
16. Colagiuri S, Walker AE. Using an economic model of diabetes to evaluate prevention and care strategies in Australia. Health Aff (Millwood). 2008;27(1):256-68.
17. Gillies CL, Lambert PC, Abrams KR, Sutton AJ, Cooper NJ, Hsu RT, et al. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ. 2008;336(7654):1180-5.
18. Engelgau MM, Narayan KM, Herman WH. Screening for type 2 diabetes. Diabetes Care. 2000;23: 1563-80.
19. Lamotte M, Piñol C, Brotons C, Annemans L, Guardiola E, Evers T, et al. Health economic evaluation of low-dose acetylsalicylic acid in the primary prevention of cardiovascular disease. Rev Esp Cardiol. 2006; 59(8):807-15.
20. Gutiérrez G, Acosta B, Pérez L, Aranda J, Medina I, Turrubiate N, et al. Encuesta Nacional de Coberturas 2006. México, DF: Instituto Mexicano del Seguro Social; 2006. Spanish.
21. Rulla JA, Aguilar-Salinas C, Rojas R, Rios-Torres JM, Gómez-Pérez FJ, Olaiz G. Epidemiology of type 2 diabetes in Mexico. Arch Intern Med. 2005;36:188-96.
22. Gutiérrez G, Pérez-Cuevas R, Levy S, Reyes H, Acosta B, Cantón SF, et al. Strengthening preventive care programs: a permanent challenge for healthcare systems; lessons from PREVENIMSS México. BMC Public Health. 2010;10:417.
23. To access the Technical Appendix, click on the Technical Appendix link in the box to the right of the article online.
24. Somannavar S, Ganesan A, Deepa M, Datta M, Mohan V. Random capillary blood glucose cut points for diabetes and pre-diabetes derived from community-based opportunistic screening in India. Diabetes Care. 2009;32(4):641-3.
25. Instituto Mexicano del Seguro Social. Reporte de gestión [Internet]. México, DF: Instituto Mexicano del Seguro Social; [cited 2010 Nov 10]. Spanish. Available from: http://www.imss.gob.mx/estadisticas/financieras/reporte_gestion.htm
26. Eastman RC, Javitt JC, Herman WH, Dasbach EJ, Zbrozek AS, Dong F, et al. Model of complications of NIDDM: I; model construction and assumptions. Diabetes Care. 1997; 20(5):725-34.
27. Barceló A, Aedo C, Swapnil R, Robles S. The cost of diabetes in Latin America and the Caribbean. Bull World Health Organ. 2003;81:19-27.
28. Reynales-Shigematsu LM, Rodríguez-Bolañs RA, Jiménez JA, Juárez-Márquez SA, Castro-Ríos A, Hernández-Avila M. [Health care costs attributable to tobacco consumption on a national level in the Mexican Institute of Social Security]. Salud Publica Mex. 2006;48(Suppl 1):S48-64. Spanish.
29. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.